Head to Head Contrast: Synergy CHC (NASDAQ:SNYR) and Kenvue (NYSE:KVUE)

Kenvue (NYSE:KVUE) and Synergy CHC (NASDAQ:SNYR) are both consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, valuation and risk.

Volatility and Risk

Kenvue has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500. Comparatively, Synergy CHC has a beta of 3.64, indicating that its stock price is 264% more volatile than the S&P 500.

Profitability

This table compares Kenvue and Synergy CHC’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kenvue	9.72%	19.72%	7.72%
Synergy CHC	7.77%	-19.51%	14.25%

Analyst Recommendations

This is a summary of recent recommendations for Kenvue and Synergy CHC, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kenvue	0	13	3	0	2.19
Synergy CHC	0	1	2	0	2.67

Kenvue currently has a consensus price target of $19.58, suggesting a potential upside of 11.81%. Synergy CHC has a consensus price target of $6.00, suggesting a potential upside of 395.91%. Given Synergy CHC’s stronger consensus rating and higher probable upside, analysts clearly believe Synergy CHC is more favorable than Kenvue.

Valuation & Earnings

This table compares Kenvue and Synergy CHC”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kenvue	$15.12 billion	2.22	$1.47 billion	$0.77	22.75
Synergy CHC	$34.83 million	0.39	$2.12 million	$0.29	4.17

Kenvue has higher revenue and earnings than Synergy CHC. Synergy CHC is trading at a lower price-to-earnings ratio than Kenvue, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

97.6% of Kenvue shares are held by institutional investors. 0.2% of Kenvue shares are held by company insiders. Comparatively, 56.6% of Synergy CHC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Kenvue beats Synergy CHC on 9 of the 14 factors compared between the two stocks.

About Kenvue

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

About Synergy CHC

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.